Related Experiment Video
Updated: May 12, 2026
06:13
Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain
Published on: March 1, 2024
[Prolonged-release tapentadol for phantom pain. A case series].
K-U Kern1, P Bialas, D Fangmann
1Institut für Schmerzmedizin/Schmerzpraxis Wiesbaden, Sonnenberger Strasse 68, Wiesbaden, Germany. dr.kern@schmerzpraxis-wiesbaden.de
Schmerz (Berlin, Germany)
|March 30, 2013
Summary
Tapentadol, a medication combining μ-opioid receptor agonism and noradrenalin re-uptake inhibition, shows promise for treating phantom limb pain. This study observed significant pain reduction and improved sleep in patients receiving this novel therapeutic approach.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Phantom limb pain presents a significant therapeutic challenge due to incompletely understood pathophysiology.
- No previous studies have investigated tapentadol for phantom limb pain treatment.
Observation:
- Five patients with upper and lower extremity phantom pain were treated with tapentadol (prolonged release).
- Doses varied among patients, and outcomes were monitored.
- Side effects were minimal, with only one patient reporting vertigo and fatigue.
Findings:
- Four patients experienced a significant reduction in pain intensity, measured on the visual analog scale (VAS).
- One patient reported a 30% decrease in phantom pain attacks and increased sleep duration from 2 to 5 hours.
- Two patients were able to reduce or extend their existing medication regimens.
Implications:
- Tapentadol's dual mechanism of action (μ-opioid receptor agonism and noradrenalin re-uptake inhibition) may offer a beneficial therapeutic strategy for phantom pain.
- These findings suggest a potential new treatment avenue for a challenging condition.
- Further research is warranted to confirm efficacy and optimize treatment protocols.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...